Please login to the form below

Not currently logged in
Email:
Password:

Generics UK

This page shows the latest Generics UK news and features for those working in and with pharma, biotech and healthcare.

NHS England’s medicines chief: stop ‘salami slicing’ and get faster market access

NHS England’s medicines chief: stop ‘salami slicing’ and get faster market access

Speaking at a UK market access summit hosted by IQVIA in London, Blake Dark said he was still in the early days of his post, and was listening to industry views ... and the company’s generics division, with his last role being co-ordinator of

Latest news

  • Warning ‘at red’ on no deal Brexit medicines chaos Warning ‘at red’ on no deal Brexit medicines chaos

    The UK pharma, biotech and generics medicines associations and the NHS’ Brexit Health Alliance and others have now called for an urgent meeting with the health secretary Matt Hancock, and say ... The EU says an agreement must be reached by the

  • Lilly wins on appeal in Alimta vitamin regimen dispute Lilly wins on appeal in Alimta vitamin regimen dispute

    The ruling finds that Actavis generics on sale in the UK, France, Italy and Spain infringe on Lilly's patents for Alimta (pemetrexed disodium), which has lost patent protection in several ... directly infringe the patents, a decision which was upheld the

  • Teva sells UK and Ireland assets to Intas Pharma for £603m Teva sells UK and Ireland assets to Intas Pharma for £603m

    Generics portfolio and manufacturing facility gain set to double Indian firm’s UK sales. ... Offloading Actavis Generics UK and Irish assets is the latest in a series of divestments by Teva to meet antitrust conditions from international regulatory

  • Lundbeck challenge to EC pay-for-delay ruling fails Lundbeck challenge to EC pay-for-delay ruling fails

    Court upholds 94m fine for paying off firms to delay launch of Celexa generics. ... The four generics companies - Generics UK, Arrow, Alpharma and Ranbaxy - were fined around 52m, and those judgments have also been upheld by the General Court of the EU.

  • UK government fines GSK over 'pay-for-delay' deals UK government fines GSK over 'pay-for-delay' deals

    Actavis which have both been fined for the involvement of various generics units. ... Former Merck subsidiary Generics (UK) Ltd and Alpharma (acquired by Actavis in 2005) had been sued by GSK for patent infringement but the cases were dropped after the

More from news
Approximately 3 fully matching, plus 24 partially matching documents found.

Latest Intelligence

  • Mylan sees the UK paving the way for an insulin game changer Mylan sees the UK paving the way for an insulin game changer

    The fertile UK landscape is an alluring springboard for biosimilars, with Mylan recording strong uptakes in previous launches. ... biosimilars. “The UK can take the lead on showing other countries how to properly manage the opportunity of

  • Deal Watch October 2016 Deal Watch October 2016

    Similarly the acquisition of Actavis (Allergan) Generics by Teva for $40.5bn has resulted in the divestment of Actavis's former factory and some products in the UK and Ireland to ... Teva (IS). Intas (IN). Asset Acquisition. Former Actavis generics

  • Pharma deals during January 2015 Pharma deals during January 2015

    This deal was of significance to Actavis as it gives the company the number 1 position for generics in the UK.

  • Proving value in uncertain times Proving value in uncertain times

    Additional pressure is being exerted in many EU markets with the introduction of new, additional barriers to access, whether it's the idea of value-based pricing in the UK or ... officially sanctioned generics prescribing targets in markets such as Spain,

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Teva appoints UK & Ireland general manager Teva appoints UK & Ireland general manager

    Promotes UK chief operating officer Kim Innes. Teva UK has promoted chief operating officer Kim Innes to general manager of its UK and Ireland business, succeeding Richard Daniell. ... She became head of Teva's generics business unit in the UK in 2006,

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
Responding to dynamic shifts in value communications
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
Doing what we can and having fun doing it: our fundraising month
Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...

Infographics